Volume 23, Number 10—October 2017
Dispatch
Diagnosis of Fatal Human Case of St. Louis Encephalitis Virus Infection by Metagenomic Sequencing, California, 2016
Table 1
Test |
Hospitalization day sample collected |
Result |
---|---|---|
Serum studies | ||
Bacterial cultures | 0, 2, 4, 7 | Negative |
Fungal cultures | 0, 2, 4, 7 | Negative |
Mycobacterial culture | 10 | Negative |
Aspergillus antigen EIA | 5 | Negative |
Adenovirus PCR | 19 | Negative |
CMV DNA quantitative PCR | 4, 12 | Negative |
EBV DNA quantitative PCR | 10 | Negative |
Enterovirus RNA | 19 | Negative |
HSV-1 and HSV-2 PCR | 12 | Negative |
HHV-6 PCR | 19 | Negative |
HIV RNA quantitative PCR | 5 | Negative |
HBV DNA quantitative PCR | 9 | Negative |
Leptospira DNA | 14 | Negative |
Parvovirus B19 DNA | 19 | Negative |
VZV DNA, qualitative PCR | 19 | Negative |
Cryptococcal antigen |
5 |
Negative |
CSF studies | ||
HSV 1 and 2 PCR | 3 | Negative |
Fungal culture | 3 | Negative |
Bacterial culture | 3 | |
Coccidioides Ab CF, ID | 8 | Negative |
CMV PCR | 9 | |
EBV PCR | 3, 9 | Negative |
HHV-6 PCR | 3 | Negative |
JC polyomavirus DNA, PCR | 9 | Negative |
Mycobacterial culture | 9 | Negative |
Mycobacterium tuberculosis DNA PCR | 10 | Negative |
Meningoencephalitis antibody panel† | 10 | Negative |
VDRL | 9 | Negative |
VZV Ab IgG | 9 | Negative |
West Nile virus RNA | 9 | Negative |
mNGS for pathogen detection |
9 |
SLEV |
Respiratory secretion testing‡ | ||
Bacterial culture | 4, 5, 8 | Candida albicans |
Fungal culture | 5, 8 | C. albicans |
Respiratory virus panel§ | 4 (NP swab), 5 | Negative |
Mycoplasma pneumoniae PCR | 5 | |
HSV-1 and HSV-2 PCR | 5 | Negative |
CMV PCR | 5 | Negative |
Pneumocystis DFA | 5 | Negative |
Mycobacterial culture | 5 | Negative |
Legionella culture and urinary Ag | 5 | Negative |
Nocardia culture |
8 |
Negative |
Serologic testing | ||
Coccidioides IgG/IgM | 4, 9 | Negative |
Coccidioides complement fixation | 8 | Negative |
HCV Ab | 9 | Negative |
HBV, core Ab and hepatitis B e Ab | 9 | Negative |
Mycobacterium tuberculosis quantiferon gold | 8 | Negative |
Q fever antibody | 8 | Negative |
Rapid plasma reagin | 10 | Negative |
*Ab, antibody; Ag, antigen; BAL, bronchoalveolar lavage; CF, complement fixation; CMV, cytomegalovirus; DFA, direct fluorescent antigen; DNA, deoxyribonucleic acid; EBV, Epstein-Barr virus; EIA, enzyme immunoassay; HBV, hepatitis B virus; HCV, hepatitis C virus; HHV-6, human herpesvirus 6; HIV, human immunodeficiency virus; HSV, herpes simplex virus; ID, immunodiffusion; IFA, indirect fluroescent antibody; mNGS, metagenomic next-generation sequencing; NP, nasopharyngeal; RNA, ribonucleic acid; SLEV, St. Louis encephalitis virus; VRDL, Venereal Disease Research Laboratory; VZV, varicella zoster virus.
†Includes IgM and IgG testing for West Nile virus; California encephalitis virus; Eastern equine encephalitis virus; St. Louis encephalitis virus; Western equine encephalitis virus; lymphocytic choriomeningitis virus; herpes simplex virus types 1 and 2 (HSV-1 and 2); adenovirus; influenza A; influenza B; measles (IFA); mumps (IFA); varicella-zoster Ab CF; coxsackie A types 2, 4, 7, 9, 10, and 16; coxsackie B types 1, 2, 3, 4, 5, and 6; echovirus types 4, 7, 9, 11, and 30; and CMV.
‡Testing performed on bronchoalveolar lavage unless noted otherwise.
§Detects the following viruses: influenza A; influenza A H1 seasonal; influenza A H3 seasonal; influenza A 2009 H1N1; influenza B; respiratory syncytial virus A and B; parainfluenza viruses 1–4; human metapneumovirus; human rhinovirus; adenovirus serogroups C and B/E; coronaviruses NL63, HKU1, 229E, and OC43.